Research article
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer
-
* Corresponding author: Mitch Raponi mraponi1@its.jnj.com
1 Johnson and Johnson Research Pty Ltd, Eveleigh, NSW, Australia
2 Veridex L.L.C., a Johnson and Johnson company, San Diego, CA, USA
3 Centocor Research & Development, Inc., Radnor, PA, USA
4 Johnson & Johnson Pharmaceutical Research & Development L.L.C., San Diego, CA, USA
5 Children's Cancer Institute Australia for Medical Research, PO Box 81 (High Street), Randwick, Sydney, NSW 2031, Australia
BMC Cancer 2009, 9:374 doi:10.1186/1471-2407-9-374
Published: 20 October 2009Additional files
Additional file 1:
Clinical Sample Characteristics. Characteristics of CRC clinical samples used in the study.
Format: XLS Size: 566KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 2:
Taqman miRNA Assays. List of 169 ABI early access miRNA Taqman assays.
Format: XLS Size: 22KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 3:
Starfire Probes. Sequences of Starfire probes used for Northern analysis.
Format: XLS Size: 37KB Download file
This file can be viewed with: Microsoft Excel Viewer